Research

Current Clinical Trials

Investigator	Title	Sponsor	Disease Area	Contact
Craig Donatucci, MD	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fesoterodine as an "Add-on" Therapy in Men with Persistent Overactive Bladder Symptoms Under Monotherapy of Alpha Blocker for Lower Urinary Tract Symptoms (Protocol A0221009)	Pfizer	Urinary Tract Symptoms	Jill Smith 919-668-3613
Craig Donatucci, MD	A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, with Open-Label Follow On, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects with Premature Ejaculation (PE) Protocol #PSD002-PE-002	Plethora Solutions	Premature Ejaculation	Jill Smith 919-668-3613
Kelly Maloney, MD	Gene Methylation Testing in Urines from Patients Undergoing: Initial Diagnostic Testing for Bladder Cancer, Monitoring for Bladder Cancer Disease Recurrence, or Receiving Immunomodulatory Treatment	OncoMethylone Sciences	Bladder Cancer	Alicia Wilkerson 919-684-6898
Judd Moul, MD	A Phase II Study of Neoadjuvant Bevacizumab plus Docetaxel in High Risk Patients with Prostate Cancer Undergoing Radical Prostatectomy	Dana Farber Genentech Sanofi-Synthelabo	Prostate Cancer	Jill Smith 919-668-3613
Thomas Polascik, MD	A Comparative Study of PET/CT versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Pre-Surgical Patients with Renal Masses Using Iodine-124 labeled Chimeric G250 (124IcG250)	Wilex AG	Renal Cell Cancer	Trish Creel 919-668-0635
Cary Robertson, MD	Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Patients with Non-Invasive Urothelial Carcinoma In Situ (CIS) Previously Treated with Bacille Calmette-Guérin (BCG) VB4-845-02-IIA	Viventia Biotech	Urothelial Cancer	Jill Smith 919-668-3613
Cary Robertson, MD	EDAP Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU) Indicated for Treatment of Low-Risk, Localized Prostate Cancer	Healthtronics	Prostate Cancer	Jill Smith 919-668-3613
David Albala, MD	Prostate Cancer Chemoprevention Clinical Trials	University of Illinois	Prostate Cancer	Trish Creel 919-668-0635
Thomas Polascik, MD	A Phase I Dose Escalation Study of Cryotherapy Followed by Radiation Therapy in Patients with Intermediate Risk, Clinically Localized Carcinoma of the Prostate	Surgery	Prostate Cancer	Vladimir Mouraviev, MD, PhD 919-684-3818
Glenn Preminger, MD	Effect of Transcutaneous Acupoint Electrical Stimulation on Urinary Symptoms and Pain in Patients Undergoing Ureteral Stent Placement Following Ureteroscopic Surgery	Surgery	Pain	Michael Ferrandino, MD 919-970-5972
Glenn Preminger, MD	Randomized Control Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy	Surgery	Kidney Stones	Barbara Mathias 919-684-6722
Glenn Preminger, MD	Effect of Transcutaneous Electrical Acupoint Stimulation on Urinary Symptoms and Pain in Patients Undergoing Percutaneous Nephrolithotomy: A Randomized, Controlled Pilot Study	Surgery	Pain	Barbara Mathias 919-684-6722
Glenn Preminger, MD	Effect of Pre-Emptive Ketorolac Administration on Post-Operative Pain and Narcotic Use in Patients Who Undergo Ambulatory Stone Procedures: A Randomized, Prospective Analysis	Surgery	Pain	Barbara Mathias 919-684-6722
Glenn Preminger, MD	A Prospective, Randomized Controlled Pilot Study of Standard Percutaneous Nephrolithotomy (PNL) versus Tubeless PNL versus Tubeless Stentless PNL	Surgery	Kidney Stones	Barbara Mathias 919-684-6722